Editor’s Note: This article is part of Joanna’s Top Trades — a weekly feature dedicated toward making you money within a specific space. Joanna’s pick for this week is Zoom (NASDAQ:ZM) as the top stock to trade this week. We all know video-calling software maker Zoom (NASDAQ:ZM). The pandemic high-flier capitalized on a stay-at-home workforce, growing
0 Comments
Tesla CEO Elon Musk gestures as he visits the construction site of Tesla’s Gigafactory in Gruenheide near Berlin, Germany, August 13, 2021. Patrick Pleul | Reuters Though the market has been volatile, analysts are spotting opportunities for upside among select companies. Tipranks is able to cut through the market noise by aggregating data to show
0 Comments
The Coronavirus, Aid, Relief, and Economic Security (CARES) Act directed lenders holding federally-backed single-family mortgages to suspend borrowers’ payments for up to a maximum of 360 days if they experienced financial hardship due to the coronavirus outbreak. Similar, but shorter (90 days) forbearance was available to owners of multi-family units with federally-backed mortgages. Subsequent legislation,
0 Comments
Restaurant stocks have had a challenging couple of years now. The U.S. economy was almost on full throttle earlier this year, nearly hitting escape velocity from the pandemic. But things turned around as the year progressed. Now we sit on variety of conflicting economic indicators — some encouraging, other flashing warning signs. And so, while
0 Comments
Revolut CEO Nikolay Storonsky speaks onstage at the TechCrunch Disrupt conference in San Francisco, California. Kimberly White | Getty Images Revolut, the global fintech player valued at $33 billion, will soon offer commission-free stock trading to U.S. customers for the first time, CNBC has learned. The start-up is set to announce Tuesday that it secured
0 Comments
Sesen Bio (NASDAQ:SESN) is a small biotech company attempting to develop a drug it calls Vicineum. SESN stock plunged last month after hitting a massive regulatory setback. Source: luchschenF / Shutterstock.com Sesen’s Vicineum aims to treat unresponsive non-muscle invasive bladder cancer using a locally administered recombinant fusion protein method. However, the Food and Drug Administration
0 Comments